This report elaborates the market size, market characteristics, and market growth of the RNAi For Therapeutic industry, and breaks down according to the type, application, and consumption area of RNAi For Therapeutic. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for RNAi For Therapeutic in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global RNAi For Therapeutic market covered in Chapter 13:
Dicerna Pharmaceuticals
Alnylam Pharmaceuticals
RXi Pharmaceuticals
Quark Pharmaceuticals
Sirnaomics
Mirna Therapeutics
Arrowhead
Gradalis
MiRagen Therapeutics
In Chapter 6, on the basis of types, the RNAi For Therapeutic market from 2015 to 2025 is primarily split into:
siRNA
miRNA
shRNA
In Chapter 7, on the basis of applications, the RNAi For Therapeutic market from 2015 to 2025 covers:
Cancer
Cardiovascular
HBV
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 RNAi For Therapeutic Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 RNAi For Therapeutic Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 RNAi For Therapeutic Market Forces
3.1 Global RNAi For Therapeutic Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 RNAi For Therapeutic Market - By Geography
4.1 Global RNAi For Therapeutic Market Value and Market Share by Regions
4.1.1 Global RNAi For Therapeutic Value ($) by Region (2015-2020)
4.1.2 Global RNAi For Therapeutic Value Market Share by Regions (2015-2020)
4.2 Global RNAi For Therapeutic Market Production and Market Share by Major Countries
4.2.1 Global RNAi For Therapeutic Production by Major Countries (2015-2020)
4.2.2 Global RNAi For Therapeutic Production Market Share by Major Countries (2015-2020)
4.3 Global RNAi For Therapeutic Market Consumption and Market Share by Regions
4.3.1 Global RNAi For Therapeutic Consumption by Regions (2015-2020)
4.3.2 Global RNAi For Therapeutic Consumption Market Share by Regions (2015-2020)
5 RNAi For Therapeutic Market - By Trade Statistics
5.1 Global RNAi For Therapeutic Export and Import
5.2 United States RNAi For Therapeutic Export and Import (2015-2020)
5.3 Europe RNAi For Therapeutic Export and Import (2015-2020)
5.4 China RNAi For Therapeutic Export and Import (2015-2020)
5.5 Japan RNAi For Therapeutic Export and Import (2015-2020)
5.6 India RNAi For Therapeutic Export and Import (2015-2020)
5.7
6 RNAi For Therapeutic Market - By Type
6.1 Global RNAi For Therapeutic Production and Market Share by Types (2015-2020)
6.1.1 Global RNAi For Therapeutic Production by Types (2015-2020)
6.1.2 Global RNAi For Therapeutic Production Market Share by Types (2015-2020)
6.2 Global RNAi For Therapeutic Value and Market Share by Types (2015-2020)
6.2.1 Global RNAi For Therapeutic Value by Types (2015-2020)
6.2.2 Global RNAi For Therapeutic Value Market Share by Types (2015-2020)
6.3 Global RNAi For Therapeutic Production, Price and Growth Rate of siRNA (2015-2020)
6.4 Global RNAi For Therapeutic Production, Price and Growth Rate of miRNA (2015-2020)
6.5 Global RNAi For Therapeutic Production, Price and Growth Rate of shRNA (2015-2020)
7 RNAi For Therapeutic Market - By Application
7.1 Global RNAi For Therapeutic Consumption and Market Share by Applications (2015-2020)
7.1.1 Global RNAi For Therapeutic Consumption by Applications (2015-2020)
7.1.2 Global RNAi For Therapeutic Consumption Market Share by Applications (2015-2020)
7.2 Global RNAi For Therapeutic Consumption and Growth Rate of Cancer (2015-2020)
7.3 Global RNAi For Therapeutic Consumption and Growth Rate of Cardiovascular (2015-2020)
7.4 Global RNAi For Therapeutic Consumption and Growth Rate of HBV (2015-2020)
8 North America RNAi For Therapeutic Market
8.1 North America RNAi For Therapeutic Market Size
8.2 United States RNAi For Therapeutic Market Size
8.3 Canada RNAi For Therapeutic Market Size
8.4 Mexico RNAi For Therapeutic Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe RNAi For Therapeutic Market Analysis
9.1 Europe RNAi For Therapeutic Market Size
9.2 Germany RNAi For Therapeutic Market Size
9.3 United Kingdom RNAi For Therapeutic Market Size
9.4 France RNAi For Therapeutic Market Size
9.5 Italy RNAi For Therapeutic Market Size
9.6 Spain RNAi For Therapeutic Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific RNAi For Therapeutic Market Analysis
10.1 Asia-Pacific RNAi For Therapeutic Market Size
10.2 China RNAi For Therapeutic Market Size
10.3 Japan RNAi For Therapeutic Market Size
10.4 South Korea RNAi For Therapeutic Market Size
10.5 Southeast Asia RNAi For Therapeutic Market Size
10.6 India RNAi For Therapeutic Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa RNAi For Therapeutic Market Analysis
11.1 Middle East and Africa RNAi For Therapeutic Market Size
11.2 Saudi Arabia RNAi For Therapeutic Market Size
11.3 UAE RNAi For Therapeutic Market Size
11.4 South Africa RNAi For Therapeutic Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America RNAi For Therapeutic Market Analysis
12.1 South America RNAi For Therapeutic Market Size
12.2 Brazil RNAi For Therapeutic Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Dicerna Pharmaceuticals
13.1.1 Dicerna Pharmaceuticals Basic Information
13.1.2 Dicerna Pharmaceuticals Product Profiles, Application and Specification
13.1.3 Dicerna Pharmaceuticals RNAi For Therapeutic Market Performance (2015-2020)
13.2 Alnylam Pharmaceuticals
13.2.1 Alnylam Pharmaceuticals Basic Information
13.2.2 Alnylam Pharmaceuticals Product Profiles, Application and Specification
13.2.3 Alnylam Pharmaceuticals RNAi For Therapeutic Market Performance (2015-2020)
13.3 RXi Pharmaceuticals
13.3.1 RXi Pharmaceuticals Basic Information
13.3.2 RXi Pharmaceuticals Product Profiles, Application and Specification
13.3.3 RXi Pharmaceuticals RNAi For Therapeutic Market Performance (2015-2020)
13.4 Quark Pharmaceuticals
13.4.1 Quark Pharmaceuticals Basic Information
13.4.2 Quark Pharmaceuticals Product Profiles, Application and Specification
13.4.3 Quark Pharmaceuticals RNAi For Therapeutic Market Performance (2015-2020)
13.5 Sirnaomics
13.5.1 Sirnaomics Basic Information
13.5.2 Sirnaomics Product Profiles, Application and Specification
13.5.3 Sirnaomics RNAi For Therapeutic Market Performance (2015-2020)
13.6 Mirna Therapeutics
13.6.1 Mirna Therapeutics Basic Information
13.6.2 Mirna Therapeutics Product Profiles, Application and Specification
13.6.3 Mirna Therapeutics RNAi For Therapeutic Market Performance (2015-2020)
13.7 Arrowhead
13.7.1 Arrowhead Basic Information
13.7.2 Arrowhead Product Profiles, Application and Specification
13.7.3 Arrowhead RNAi For Therapeutic Market Performance (2015-2020)
13.8 Gradalis
13.8.1 Gradalis Basic Information
13.8.2 Gradalis Product Profiles, Application and Specification
13.8.3 Gradalis RNAi For Therapeutic Market Performance (2015-2020)
13.9 MiRagen Therapeutics
13.9.1 MiRagen Therapeutics Basic Information
13.9.2 MiRagen Therapeutics Product Profiles, Application and Specification
13.9.3 MiRagen Therapeutics RNAi For Therapeutic Market Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America RNAi For Therapeutic Market Forecast (2020-2025)
14.2 Europe RNAi For Therapeutic Market Forecast (2020-2025)
14.3 Asia-Pacific RNAi For Therapeutic Market Forecast (2020-2025)
14.4 Middle East and Africa RNAi For Therapeutic Market Forecast (2020-2025)
14.5 South America RNAi For Therapeutic Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global RNAi For Therapeutic Market Forecast by Types (2020-2025)
15.1.1 Global RNAi For Therapeutic Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global RNAi For Therapeutic Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global RNAi For Therapeutic Market Forecast by Applications (2020-2025)
List of Tables and Figures
Figure RNAi For Therapeutic Picture
Table RNAi For Therapeutic Key Market Segments
Figure Study and Forecasting Years
Figure Global RNAi For Therapeutic Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global RNAi For Therapeutic Value ($) and Growth Rate (2015-2020)
Table Global RNAi For Therapeutic Value ($) by Countries (2015-2020)
Table Global RNAi For Therapeutic Value Market Share by Regions (2015-2020)
Figure Global RNAi For Therapeutic Value Market Share by Regions in 2019
Figure Global RNAi For Therapeutic Production and Growth Rate (2015-2020)
Table Global RNAi For Therapeutic Production by Major Countries (2015-2020)
Table Global RNAi For Therapeutic Production Market Share by Major Countries (2015-2020)
Figure Global RNAi For Therapeutic Production Market Share by Regions in 2019
Figure Global RNAi For Therapeutic Consumption and Growth Rate (2015-2020)
Table Global RNAi For Therapeutic Consumption by Regions (2015-2020)
Table Global RNAi For Therapeutic Consumption Market Share by Regions (2015-2020)
Figure Global RNAi For Therapeutic Consumption Market Share by Regions in 2019
Table Global RNAi For Therapeutic Export Top 3 Country 2019
Table Global RNAi For Therapeutic Import Top 3 Country 2019
Table United States RNAi For Therapeutic Export and Import (2015-2020)
Table Europe RNAi For Therapeutic Export and Import (2015-2020)
Table China RNAi For Therapeutic Export and Import (2015-2020)
Table Japan RNAi For Therapeutic Export and Import (2015-2020)
Table India RNAi For Therapeutic Export and Import (2015-2020)
Table Global RNAi For Therapeutic Production by Types (2015-2020)
Table Global RNAi For Therapeutic Production Market Share by Types (2015-2020)
Figure Global RNAi For Therapeutic Production Share by Type (2015-2020)
Table Global RNAi For Therapeutic Value by Types (2015-2020)
Table Global RNAi For Therapeutic Value Market Share by Types (2015-2020)
Figure Global RNAi For Therapeutic Value Share by Type (2015-2020)
Figure Global siRNA Production and Growth Rate (2015-2020)
Figure Global siRNA Price (2015-2020)
Figure Global miRNA Production and Growth Rate (2015-2020)
Figure Global miRNA Price (2015-2020)
Figure Global shRNA Production and Growth Rate (2015-2020)
Figure Global shRNA Price (2015-2020)
Table Global RNAi For Therapeutic Consumption by Applications (2015-2020)
Table Global RNAi For Therapeutic Consumption Market Share by Applications (2015-2020)
Figure Global RNAi For Therapeutic Consumption Share by Application (2015-2020)
Figure Global Cancer Consumption and Growth Rate (2015-2020)
Figure Global Cardiovascular Consumption and Growth Rate (2015-2020)
Figure Global HBV Consumption and Growth Rate (2015-2020)
Figure North America RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Table North America RNAi For Therapeutic Consumption by Countries (2015-2020)
Table North America RNAi For Therapeutic Consumption Market Share by Countries (2015-2020)
Figure North America RNAi For Therapeutic Consumption Market Share by Countries (2015-2020)
Figure United States RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure Canada RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure Mexico RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Table Europe RNAi For Therapeutic Consumption by Countries (2015-2020)
Table Europe RNAi For Therapeutic Consumption Market Share by Countries (2015-2020)
Figure Europe RNAi For Therapeutic Consumption Market Share by Countries (2015-2020)
Figure Germany RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure France RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure Italy RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure Spain RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific RNAi For Therapeutic Consumption by Countries (2015-2020)
Table Asia-Pacific RNAi For Therapeutic Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific RNAi For Therapeutic Consumption Market Share by Countries (2015-2020)
Figure China RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure Japan RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure South Korea RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure India RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa RNAi For Therapeutic Consumption by Countries (2015-2020)
Table Middle East and Africa RNAi For Therapeutic Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa RNAi For Therapeutic Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure UAE RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure South Africa RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Figure South America RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Table South America RNAi For Therapeutic Consumption by Countries (2015-2020)
Table South America RNAi For Therapeutic Consumption Market Share by Countries (2015-2020)
Figure South America RNAi For Therapeutic Consumption Market Share by Countries (2015-2020)
Figure Brazil RNAi For Therapeutic Market Consumption and Growth Rate (2015-2020)
Table Dicerna Pharmaceuticals Company Profile
Table Dicerna Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Dicerna Pharmaceuticals Production and Growth Rate
Figure Dicerna Pharmaceuticals Value ($) Market Share 2015-2020
Table Alnylam Pharmaceuticals Company Profile
Table Alnylam Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Alnylam Pharmaceuticals Production and Growth Rate
Figure Alnylam Pharmaceuticals Value ($) Market Share 2015-2020
Table RXi Pharmaceuticals Company Profile
Table RXi Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure RXi Pharmaceuticals Production and Growth Rate
Figure RXi Pharmaceuticals Value ($) Market Share 2015-2020
Table Quark Pharmaceuticals Company Profile
Table Quark Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Quark Pharmaceuticals Production and Growth Rate
Figure Quark Pharmaceuticals Value ($) Market Share 2015-2020
Table Sirnaomics Company Profile
Table Sirnaomics Production, Value, Price, Gross Margin 2015-2020
Figure Sirnaomics Production and Growth Rate
Figure Sirnaomics Value ($) Market Share 2015-2020
Table Mirna Therapeutics Company Profile
Table Mirna Therapeutics Production, Value, Price, Gross Margin 2015-2020
Figure Mirna Therapeutics Production and Growth Rate
Figure Mirna Therapeutics Value ($) Market Share 2015-2020
Table Arrowhead Company Profile
Table Arrowhead Production, Value, Price, Gross Margin 2015-2020
Figure Arrowhead Production and Growth Rate
Figure Arrowhead Value ($) Market Share 2015-2020
Table Gradalis Company Profile
Table Gradalis Production, Value, Price, Gross Margin 2015-2020
Figure Gradalis Production and Growth Rate
Figure Gradalis Value ($) Market Share 2015-2020
Table MiRagen Therapeutics Company Profile
Table MiRagen Therapeutics Production, Value, Price, Gross Margin 2015-2020
Figure MiRagen Therapeutics Production and Growth Rate
Figure MiRagen Therapeutics Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global RNAi For Therapeutic Market Forecast Production by Types (2020-2025)
Table Global RNAi For Therapeutic Market Forecast Production Share by Types (2020-2025)
Table Global RNAi For Therapeutic Market Forecast Value ($) by Types (2020-2025)
Table Global RNAi For Therapeutic Market Forecast Value Share by Types (2020-2025)
Table Global RNAi For Therapeutic Market Forecast Consumption by Applications (2020-2025)
Table Global RNAi For Therapeutic Market Forecast Consumption Share by Applications (2020-2025)
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|